Does the mobilization of circulating tumour cells during cancer therapy cause metastasis? (Q38934490)

7 September 2017

1 reference

title

Does the mobilization of circulating tumour cells during cancer therapy cause metastasis? (English)

1 reference

7 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27550857%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27550857%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Olga A Martin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27550857%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Kailash Narayan

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27550857%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

language of work or name

English

0 references

publication date

23 August 2016

1 reference

Nature Reviews Clinical Oncology

7 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27550857%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27550857%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27550857%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

32-44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27550857%20AND%20SRC:MED&resulttype=core&format=json

Circulating epithelial cells in patients with benign colon diseases

13 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Systemic spread is an early step in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Gene expression profiles of primary breast tumors maintained in distant metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Circulating tumour cells in non-metastatic breast cancer: a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Detection of cancer before distant metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Parallel progression of primary tumours and metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Using tumour phylogenetics to identify the roots of metastasis in humans.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Mechanisms of disseminated cancer cell dormancy: an awakening field

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Clinical implications of cancer self-seeding

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

The evolutionary history of lethal metastatic prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Loss of heterozygosity at tumor suppressor genes detectable on fractionated circulating cell-free tumor DNA as indicator of breast cancer progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Changes in mutational status during third-line treatment for metastatic colorectal cancer--results of consecutive measurement of cell free DNA, KRAS and BRAF in the plasma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Epithelial-to-mesenchymal transitions and circulating tumor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Cancer cell interactions with injured or activated endothelium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Classifying collective cancer cell invasion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Tumor interstitial fluid pressure-a link between tumor hypoxia, microvascular density, and lymph node metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Mena invasive (MenaINV) promotes multicellular streaming motility and transendothelial migration in a mouse model of breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Circulating tumor cells as a window on metastasis biology in lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Mobilization of viable tumor cells into the circulation during radiation therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Organoid cultures derived from patients with advanced prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

The distribution of secondary growths in cancer of the breast. 1889

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Radiation enhancement of metastasis: a review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

The effect of low-dose pre-operative X-irradiation of implanted mouse mammary carcinomas on local recurrence and metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Increased metastatic dissemination in human melanoma xenografts after subcurative radiation treatment: radiation-induced increase in fraction of hypoxic cells and hypoxia-induced up-regulation of urokinase-type plasminogen activator receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Establishment of animal model for the analysis of cancer cell metastasis during radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Radiation enhances long-term metastasis potential of residual hepatocellular carcinoma in nude mice through TMPRSS4-induced epithelial–mesenchymal transition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Radiation therapy may increase metastatic potential in alveolar rhabdomyosarcoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Radiation oncology: a century of achievements.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Radiation-induced cell death mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Radiation-induced apoptosis: Relevance to radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Autophagy and ionizing radiation in tumors: the "survive or not survive" dilemma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Cancer stem cells as a predictive factor in radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Clinical perspectives of cancer stem cell research in radiation oncology.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Sensing and repairing DNA double-strand breaks

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Delayed cell death, giant cell formation and chromosome instability induced by X-irradiation in human embryo cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

X-ray radiation promotes the metastatic potential of tongue squamous cell carcinoma cells via modulation of biomechanical and cytoskeletal properties

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Radiation promotes invasiveness of non-small-cell lung cancer cells through granulocyte-colony-stimulating factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Recruitment of circulating breast cancer cells is stimulated by radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Sublethal irradiation induces vascular endothelial growth factor and promotes growth of hepatoma cells: implications for radiotherapy of hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Low doses of ionizing radiation promote tumor growth and metastasis by enhancing angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Ionizing radiation induces tumor cell lysyl oxidase secretion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Adjuvant radiotherapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Radiotherapy: A double-edged sword for NSCLC?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Use of the γ-H2AX assay to monitor DNA damage and repair in translational cancer research

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Tracking viable circulating tumor cells (CTCs) in the peripheral blood of non-small cell lung cancer (NSCLC) patients undergoing definitive radiation therapy: pilot study results

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Circulating tumour cells in prostate cancer patients receiving salvage radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Building immunity to cancer with radiation therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Spectrum of cancer risk among US solid organ transplant recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Ionizing radiation predisposes nonmalignant human mammary epithelial cells to undergo transforming growth factor beta induced epithelial to mesenchymal transition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Role of Bmi-1 in regulation of ionizing irradiation-induced epithelial-mesenchymal transition and migration of breast cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Radiation promotes malignant phenotypes through SRC in breast cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Induced sensitization of tumor stroma leads to eradication of established cancer by T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

The DNA damage response and immune signaling alliance: Is it good or bad? Nature decides when and where.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Immunological aspects of radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

To SABR or not to SABR? Indications and contraindications for stereotactic ablative radiotherapy in the treatment of early-stage, oligometastatic, or oligoprogressive non-small cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Surgery versus SABR for resectable non-small-cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Stereotactic ablative body radiotherapy combined with immunotherapy: present status and future perspectives.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by positron emission tomography and treated with curative intent

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Prognostic significance of lymphovascular space invasion and nodal involvement in intermediate- and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Surgery, wound healing, and metastasis: recent insights and clinical implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Wound implantation—a surgical hazard

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Can anaesthetic and analgesic techniques affect cancer recurrence or metastasis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Effect of anaesthetic technique on the natural killer cell anti-tumour activity of serum from women undergoing breast cancer surgery: a pilot study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Anesthesia and cancer recurrence: What is the evidence?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

The effects of surgery on tumor growth: a century of investigations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Exploiting the critical perioperative period to improve long-term cancer outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Stimulation of tumour growth by wound-derived growth factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Transrectal ultrasound-guided biopsy causes hematogenous dissemination of prostate cells as determined by RT-PCR.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Influence of sextant prostate needle biopsy or surgery on the detection and harvest of intact circulating prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Dissemination of cancer cells into circulation occurs by incisional biopsy of oral squamous cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Needle track dissemination of follicular thyroid carcinoma following fine-needle aspiration biopsy: report of a case.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Biopsy of resectable colorectal liver metastases causes tumour dissemination and adversely affects survival after liver resection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Risk of dissemination with biopsy of colorectal liver metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Novel anti-seeding technology to prevent dissemination of tumor cells after a fine-needle aspiration biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Prevention of tumour cell dissemination in diagnostic needle procedures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Hematogenous tumor cell dissemination during colonoscopy for colorectal cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Increased detection rate and potential prognostic impact of disseminated tumor cells in patients undergoing endorectal ultrasound for rectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Biology and significance of circulating and disseminated tumour cells in colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Compartmental differences of circulating tumor cells in colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Detection of disseminated tumor cells in liver biopsies of colorectal cancer patients is not associated with a worse prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Circulating tumour cells during laparoscopic and open surgery for primary colonic cancer in portal and peripheral blood

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Neoadjuvant radiotherapy for rectal cancer: meta-analysis of randomized controlled trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Evaluation of prognostic significance of circulating tumor cells detection in rectal cancer patients treated with preoperative radiotherapy: prospectively collected material data.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Recurrence dynamics does not depend on the recurrence site.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Hazard rates of recurrence following diagnosis of primary breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Tumor dissemination after video-assisted thoracic surgery: What does it mean?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Detection of circulating tumor cells in patients with non-small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: a potential hazard for intraoperative hematogenous tumor cell dissemination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Significant increase in circulating tumour cells in pulmonary venous blood during surgical manipulation in patients with primary lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Hematogenous dissemination of lung cancer cells during surgery: quantitative detection by flow cytometry and prognostic significance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Assessment of the effect of surgery on the kinetics of circulating tumour cells in patients with operable breast cancer based on cytokeratin-19 mRNA detection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Transurethral bladder tumor resection can cause seeding of cancer cells into the bloodstream

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Clinical significance of circulating tumor cells in blood by molecular detection and tumor markers in esophageal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Concomitant surgery for renal neoplasm with pulmonary tumor embolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Role of lymphatic vasculature in regional and distant metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Prognostic value of circulating inflammatory factors in non-small cell lung cancer: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Effects of different sequences of pulmonary artery and vein ligations during pulmonary lobectomy on blood micrometastasis of non-small cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Antiangiogenic therapy: impact on invasion, disease progression, and metastasis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Therapy-induced tumour secretomes promote resistance and tumour progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Intravenous pulse administration of cyclophosphamide is an effective and safe treatment for sensitized cardiac allograft recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Cyclophosphamide promotes pulmonary metastasis on mouse lung adenocarcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Induction of cancer metastasis by cyclophosphamide pretreatment of host mice: an opposite effect of chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Prognostic Role of Circulating Tumor Cells during Induction Chemotherapy Followed by Curative Surgery Combined with Postoperative Radiotherapy in Patients with Locally Advanced Oral and Oropharyngeal Squamous Cell Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Long-term survival after high-dose chemotherapy with autologous hematopoietic cell transplantation in metastatic breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

BMP4 inhibits breast cancer metastasis by blocking myeloid-derived suppressor cell activity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Erythropoietin and cancer: the unintended consequences of anemia correction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Long-term results of radiation therapy oncology group 9903: a randomized phase 3 trial to assess the effect of erythropoietin on local-regional control in anemic patients treated with radiation therapy for squamous cell carcinoma of the head and nec

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.128

Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin

31 March 2020

1 reference

12 December 2020

Reverse transcriptase polymerase chain reaction study to evaluate dissemination of cancer cells into circulation after incision biopsy in oral squamous cell carcinoma.

1 reference

12 December 2020

Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC).

1 reference

12 December 2020

Isolation of prostate-derived single cells and cell clusters from human peripheral blood

1 reference

12 December 2020

The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture.

1 reference

12 December 2020

Surgery or stereotactic ablative radiation therapy: how will be treated operable patients with early stage not small cell lung cancer in the next future?

1 reference

12 December 2020

The effect of local roentgen irradiation on the biological behavior of a transplantable mouse carcinoma; increased frequency of pulmonary metastasis

1 reference

12 December 2020

Immunosuppression in irradiated breast cancer patients: in vitro effect of cyclooxygenase inhibitors

1 reference

12 December 2020

Mobilization of tumour cells during biopsy in an infant with Ewing sarcoma

1 reference

12 December 2020

Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation

1 reference

12 December 2020

CTC enumeration and characterization: moving toward personalized medicine

1 reference

12 December 2020

Cyclophosphamide induces type I interferon and augments the number of CD44(hi) T lymphocytes in mice: implications for strategies of chemoimmunotherapy of cancer

1 reference

12 December 2020

Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy

1 reference

12 December 2020

Prostate cancer and other xenografts from cells in peripheral blood of patients

1 reference

12 December 2020

Dissemination of tumor cells in patients undergoing surgery for colorectal cancer

1 reference

12 December 2020

The significance of hematogenous tumor cell clumps in the metastatic process

1 reference

12 December 2020

Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023

1 reference

12 December 2020

Radiation therapy to a primary tumor accelerates metastatic growth in mice

1 reference

12 December 2020

Decreased detection rate of disseminated tumor cells of rectal cancer patients after preoperative chemoradiation: a first step towards a molecular surrogate marker for neoadjuvant treatment in colorectal cancer

1 reference

12 December 2020